Related Experiment Video
Updated: Feb 16, 2026

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
Published on: November 14, 2016
Leptomeningeal Contrast Enhancement Is Associated with Disability Progression and Grey Matter Atrophy in Multiple
Gleb Makshakov1,2, Evgeniy Magonov3, Natalia Totolyan2
1SBIH City Clinical Hospital No. 31, City Center of MS and Autoimmune Diseases, St. Petersburg, Russia.
Abstract:
Leptomeningeal contrast enhancement (LMCE) on magnetic resonance imaging (MRI) is a newly recognized possible biomarker in multiple sclerosis (MS), associated with MS progression and cortical atrophy. In this study, we aimed to assess the prevalence of LMCE foci and their impact on neurodegeneration and disability. Materials. 54 patients with MS were included in the study. LMCE were detected with a 3 Tesla scanner on postcontrast fluid-attenuated inversion-recovery (FLAIR) sequence. Expanded Disability Status Scale (EDSS) score, number of relapses during 5 years from MS onset, and number of contrast-enhancing lesions on T1 weighted MRI were counted. Results. LMCE was detected in 41% (22/54) of patients. LMCE-positive patients had longer disease duration (p = 0,0098) and higher EDSS score (p = 0,039), but not a higher relapse rate (p = 0,091). No association of LMCE with higher frequency of contrast-enhancing lesions on T1-weighted images was detected (p = 0,3842). Analysis of covariates, adjusted for age, sex, and disease duration, revealed a significant effect of LMCE on the cortex volume (p = 0.043, F = 2.529), the total grey matter volume (p = 0.043, F = 2.54), and total ventricular volume (p = 0.039, F = 2.605). Conclusions. LMCE was shown to be an independent and significant biomarker of grey matter atrophy and disability in MS.
Insights
Leptomeningeal contrast enhancement (LMCE) on MRI is a new biomarker for multiple sclerosis (MS). This study found LMCE is linked to greater grey matter atrophy and disability in MS patients.
Area of Science:
- Neurology
- Radiology
- Biomarkers
Background:
- Leptomeningeal contrast enhancement (LMCE) on MRI is an emerging biomarker in multiple sclerosis (MS).
- LMCE is associated with MS progression and cortical atrophy.
- The clinical significance of LMCE in MS requires further investigation.
Purpose of the Study:
- To determine the prevalence of LMCE foci in MS patients.
- To assess the impact of LMCE on neurodegeneration and patient disability.
- To evaluate LMCE as a potential independent biomarker in MS.
Main Methods:
- 54 MS patients underwent MRI using a 3 Tesla scanner with postcontrast FLAIR sequences to detect LMCE.
- Clinical data collected included Expanded Disability Status Scale (EDSS) scores and relapse rates.
- Cortical volume, grey matter volume, and ventricular volume were analyzed in relation to LMCE presence.
Main Results:
- LMCE was detected in 41% of MS patients.
- LMCE-positive patients exhibited longer disease duration and higher EDSS scores.
- LMCE significantly correlated with reduced cortex and total grey matter volume, and increased ventricular volume, independent of age, sex, and disease duration.
Conclusions:
- Leptomeningeal contrast enhancement (LMCE) is a prevalent finding in MS patients.
- LMCE serves as an independent and significant biomarker for grey matter atrophy and disability in MS.
- LMCE holds potential as a prognostic marker in multiple sclerosis management.
Related Concept Videos
Classifying Matter by State
Intellectual Disability
Learning Disabilities
Dyslexia
Dyslexia is a...
The Atomic Theory of Matter
Classifying Matter by Composition
According to its composition, the matter can be classified into two broad categories — pure substances and mixtures.
A pure substance is a form of matter that has a constant composition throughout with uniform properties. For example, any sample of sucrose has the same composition and same physical properties, such as melting point, color, and sweetness, regardless of the source from which it is isolated.
A mixture is composed of two or...
Physical and Chemical Properties of Matter

